Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Renal cell carcinoma in children and young adults: clinicopathological, immunohistochemical, and VHL gene analysis of 46 cases with follow-up.

Rao Q, Chen JY, Wang JD, Ma HH, Zhou HB, Lu ZF, Zhou XJ.

Int J Surg Pathol. 2011 Apr;19(2):170-9. doi: 10.1177/1066896909354337. Epub 2009 Dec 24.

PMID:
20034980
2.

[Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].

Rao Q, Zhou J, Zhang RS, Ma HH, Zhou HB, Lu ZF, Zhou XJ.

Zhonghua Bing Li Xue Za Zhi. 2010 Sep;39(9):582-6. Chinese.

PMID:
21092583
4.

TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.

Rao Q, Williamson SR, Zhang S, Eble JN, Grignon DJ, Wang M, Zhou XJ, Huang W, Tan PH, Maclennan GT, Cheng L.

Am J Surg Pathol. 2013 Jun;37(6):804-15. doi: 10.1097/PAS.0b013e31827e17cb.

PMID:
23598965
5.

The expression pattern of Von Hippel-Lindau tumor suppressor protein, MET proto-oncogene, and TFE3 transcription factor oncoprotein in renal cell carcinoma in Upper Egypt.

Nagi FM, Omar AA, Mostafa MG, Mohammed EA, Abd-Elwahed Hussein MR.

Ultrastruct Pathol. 2011 Apr;35(2):79-86. doi: 10.3109/01913123.2010.544844.

PMID:
21299348
6.

Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.

Clifford SC, Walsh S, Hewson K, Green EK, Brinke A, Green PM, Gianelli F, Eng C, Maher ER.

Genes Chromosomes Cancer. 1999 Sep;26(1):20-8.

PMID:
10441001
7.

Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.

Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MM, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA, et al.

Hum Mol Genet. 1994 Dec;3(12):2169-73.

PMID:
7881415
8.

Morphologic and molecular characterization of renal cell carcinoma in children and young adults.

Bruder E, Passera O, Harms D, Leuschner I, Ladanyi M, Argani P, Eble JN, Struckmann K, Schraml P, Moch H.

Am J Surg Pathol. 2004 Sep;28(9):1117-32.

PMID:
15316311
9.

Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.

Phillips JL, Ghadimi BM, Wangsa D, Padilla-Nash H, Worrell R, Hewitt S, Walther M, Linehan WM, Klausner RD, Ried T.

Genes Chromosomes Cancer. 2001 May;31(1):1-9.

PMID:
11284029
10.

MDCT findings of renal cell carcinoma associated with Xp11.2 translocation and TFE3 gene fusion and papillary renal cell carcinoma.

Woo S, Kim SY, Lee MS, Moon KC, Kim SH, Cho JY, Kim SH.

AJR Am J Roentgenol. 2015 Mar;204(3):542-9. doi: 10.2214/AJR.14.12950.

PMID:
25714283
11.

Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.

Hayes M, Peckova K, Martinek P, Hora M, Kalusova K, Straka L, Daum O, Kokoskova B, Rotterova P, Pivovarčikova K, Branzovsky J, Dubova M, Vesela P, Michal M, Hes O.

Virchows Arch. 2015 Mar;466(3):313-22. doi: 10.1007/s00428-014-1702-7. Epub 2014 Dec 28.

PMID:
25544614
12.

Renal cell carcinoma with leiomyomatous stroma--further immunohistochemical and molecular genetic characteristics of unusual entity.

Peckova K, Grossmann P, Bulimbasic S, Sperga M, Perez Montiel D, Daum O, Rotterova P, Kokoskova B, Vesela P, Pivovarcikova K, Bauleth K, Branzovsky J, Dubova M, Hora M, Michal M, Hes O.

Ann Diagn Pathol. 2014 Oct;18(5):291-6. doi: 10.1016/j.anndiagpath.2014.08.004. Epub 2014 Aug 15.

PMID:
25175809
13.

MiT family translocation renal cell carcinoma.

Argani P.

Semin Diagn Pathol. 2015 Mar;32(2):103-13. doi: 10.1053/j.semdp.2015.02.003. Epub 2015 Feb 4. Review.

PMID:
25758327
14.

TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.

Xu Y, Rao Q, Xia Q, Shi S, Shi Q, Ma H, Lu Z, Chen H, Zhou X.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):2690-9. eCollection 2015.

15.

Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.

Mosquera JM, Dal Cin P, Mertz KD, Perner S, Davis IJ, Fisher DE, Rubin MA, Hirsch MS.

Diagn Mol Pathol. 2011 Sep;20(3):129-37. doi: 10.1097/PDM.0b013e31820e9c67.

PMID:
21817901
16.

Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.

Zhuang Z, Gnarra JR, Dudley CF, Zbar B, Linehan WM, Lubensky IA.

Mod Pathol. 1996 Aug;9(8):838-42.

PMID:
8871925
17.

Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma.

Brauch H, Weirich G, Hornauer MA, Störkel S, Wöhl T, Brüning T.

J Natl Cancer Inst. 1999 May 19;91(10):854-61.

PMID:
10340905
18.

Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.

Geller JI, Argani P, Adeniran A, Hampton E, De Marzo A, Hicks J, Collins MH.

Cancer. 2008 Apr 1;112(7):1607-16. doi: 10.1002/cncr.23331.

19.

Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.

Green WM, Yonescu R, Morsberger L, Morris K, Netto GJ, Epstein JI, Illei PB, Allaf M, Ladanyi M, Griffin CA, Argani P.

Am J Surg Pathol. 2013 Aug;37(8):1150-63. doi: 10.1097/PAS.0b013e31828a69ae.

PMID:
23715164
20.

Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.

Argani P, Olgac S, Tickoo SK, Goldfischer M, Moch H, Chan DY, Eble JN, Bonsib SM, Jimeno M, Lloreta J, Billis A, Hicks J, De Marzo AM, Reuter VE, Ladanyi M.

Am J Surg Pathol. 2007 Aug;31(8):1149-60.

PMID:
17667536

Supplemental Content

Support Center